Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (10): 1110-1117.doi: 10.3736/jcim20111012

• Original Experimental Research • Previous Articles     Next Articles

Inhibitory effects of osthole, psoralen and aconitine on invasive activities of breast cancer MDA-MB-231BO cell line and the mechanisms

Bao-feng Guo, Sheng Liu(), Yi-yi Ye, Xiang-hui Han   

  1. Pharmacological Laboratory of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2011-04-15 Accepted:2011-05-09 Online:2011-10-20 Published:2011-10-15
  • Contact: Liu Sheng E-mail:yige823@yahoo.com.cn

Objective: To explore the inhibitory effects and to investigate the mechanisms of combined treatment of osthole, psoralen with aconitine on human breast cancer cell line MDA-MB-231BO.

Methods: The best inhibitory concentration of osthole, psoralen combined with aconitine on MDA-MB-231BO cells was obtained by stepwise regression analysis after adopting a uniform experiment design. The invasive activities were observed by transwell assays, and expressions of transforming growth factor-β1 (TGF-β1), Smad2, Smad3, Smad4, Smad7, nuclear factor-κB (NF-κB) and receptor activator of NF-κB ligand (RANK) mRNAs were analyzed by real-time quantitative polymerase chain reaction.

Results: The optimal combination concentrations of osthol, psoralen and aconitine were 6.44, 8.89 and 9.44 μg/mL, respectively. Cell invasion was significantly inhibited after 24 hours of treatment using the combination drugs and zoledronic acid. TGF-β1, Smad2, Smad3, Smad4, Smad7, NF-κB and RANK mRNA expressions of the optimal combination group and zoledronic acid group were significantly reduced compared with the control group (P<0.01). Furthermore, TGF-β1, Smad2, Smad3, Smad4, Smad7, NF-κB and RANK mRNA expressions of the optimal combination group were significantly lower than those of the weak combination group (P<0.01).

Conclusion: Combination treatment of osthole, psoralen with aconitine can inhibit cancer cell invasion, which is a result of alteration of the TGF-β/Smad signaling pathway and down-regulation of NF-κB and RANK expressions.

Key words: plant extracts, osthole, psoralen, aconitine, breast neoplasm, neoplasm invasiveness

Table 1

Schedule of the uniform design (μg/mL)"


Number

X1 (osthol)

X2 (psoralen)

X3 (aconitine)

1

2.00

7.22

8.33

2

2.89

10.00

6.11

3

3.78

6.67

10.00

4

4.67

9.44

7.78

5

5.56

6.11

5.56

6

6.44

8.89

9.44

7

7.33

5.56

7.22

8

8.22

8.33

5.00

9

9.11

5.00

8.89

10

10.00

7.78

6.67

Table 2

TaqMan primers for gene members"


Gene

Primer sequence (5′→3′)

Product size (bp)

Annealing temperature (℃)

TGF-β1

F: AGCGACTCGCCAGAGTGGTTA

R: GCAGTGTGTTATCCCTGCTGTCA

130

58

Smad2

F: TTAACCGAAATGCCACGGTAGAA

R: GCTCTGCACAAAGATTGCACTATCA

122

62

Smad3

F: AGGCGTGCGGCTCTACTACATC

R: CAGCGAACTCCTGGTTGTTGAA

173

58

Smad4

F: CAGCACTACCACCTGGACTGGA

R: CTGGAATGCAAGCTCATTGTGAA

145

62

Smad7

F: TGCTGTGCAAAGTGTTCAGGTG

R: CCATCGGGTATCTGGAGTAAGGA

177

58

NF-κB

F: GCCTCCACAAGGCAGCAAATA

R: CACCACTGGTCAGAGACTCGGTAA

160

62

RANK

F: TTGTGGCCGCCTAAGTGGA

R: ACCACCTTGATCTGGGTAGCACATA

160

58

GAPDH

F: GCACCGTCAAGGCTGAGAAC

R: TGGTGAAGACGCCAGTGGA

138

62

Table 3

Effects of the uniform design-based combinations on osthole, psoralen and aconitine"


Group

Osthole (μg/mL)

Psoralen (μg/mL)

Aconitine (μg/mL)

Optical density value ($\overline{x}$±s)

1

2.00

7.22

8.33

0.62±0.05

2

2.89

10.00

6.11

0.46±0.03

3

3.78

6.67

10.00

0.51±0.04

4

4.67

9.44

7.78

0.56±0.03

5

5.56

6.11

5.56

0.68±0.04

6

6.44

8.89

9.44

0.43±0.03

7

7.33

5.56

7.22

0.50±0.03

8

8.22

8.33

5.00

0.53±0.04

9

9.11

5.00

8.89

0.57±0.03

10

10.00

7.78

6.67

0.53±0.05

Figure 1

Effects of three components on cell invasion ability after treatment of MDA-MB-231BO cells for 24 h C: Control group; L: Weak combination group; H: Optimal combination group; Y: Zoledronic acid injection group. MDA-MB-231BO cells were observed under a DPFO Olympus microscope by HE staining, ×400). Data were represented as $\overline{x}$±s, n=5. **P<0.01, vs control group; △△P<0.01, vs L group."

Table 4

mRNA expressions in MDA-MB-231BO cells after medicine treatment"


Group

n

Smad7/β-actin

Smad2/β-actin

Smad3/β-actin

Smad4/β-actin

C

5

1

1

1

1

L

5

1.220±0.050

1.385±0.100

0.585±0.040

0.222±0.020

H

5

1.051±0.030**△△

0.500±0.040**△△

0.104±0.010**△△

0.151±0.010**△△

Y

5

1.033±0.020*

0.484±0.040**

0.090±0.005**

0.118±0.010**

Group

n

TGF-β1/β-actin

NF-κB/β-actin

RANK/β-actin

C

5

1

1

1

L

5

0.900±0.050

0.329±0.010

0.627±0.030

H

5

0.475±0.040**△△

0.210±0.010**△△

0.015±0.009**△△

Y

5

0.390±0.030**

0.600±0.020**

0.498±0.030**
[1] Yang D, Gu T, Wang T, Tang Q, Ma C . Effects of osthole on migration and invasion in breast cancer cells[J]. Biosci Biotechnol Biochem, 2010,74(7):1430-1434
doi: 10.1271/bbb.100110 pmid: 20622464
[2] You L, An R, Wang X, Li Y . Discovery of novel osthole derivatives as potential anti-breast cancer treatment[J]. Bioorg Med Chem Lett, 2010,20(24):7426-7428
doi: 10.1016/j.bmcl.2010.10.027 pmid: 21051232
[3] Lin VC, Chou CH, Lin YC, Lin JN, Yu CC, Tang CH, Lin HY, Way TD . Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt/mTOR pathway[J]. J Agric Food Chem, 2010,58(8):4786-4793
doi: 10.1021/jf100352c
[4] Oliveira AM, Raposo MM, Oliveira-Campos AM, Machado AE, Puapairoj P, Pedro M, Nascimento MS, Portela C, Afonso C, Pinto M . Psoralen analogues: synjournal, inhibitory activity of growth of human tumor cell lines and computational studies[J]. Eur J Med Chem, 2006,41(3):367-372
doi: 10.1016/j.ejmech.2005.10.016
[5] Fraser SP, Salvador V, Manning EA, Mizal J, Altun S, Raza M, Berridge RJ, Djamgoz MB . Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: Ⅰ. Lateral motility[J]. J Cell Physiol, 2003,195(3):479-487
doi: 10.1002/(ISSN)1097-4652
[6] 刘胜, 宋晓耘, 吴春宇, 韩向晖, 刘玲琳, 刘建文, 徐祎春 . 蛇床子和补骨脂含药血清对乳腺癌高转移细胞MDA-MB-231BO与骨髓基质细胞ST2的影响[J]. 中西医结合学报, 2010,8(9):877-882
Liu S, Song XY, Wu CY, Han XH, Liu LL, Liu JW, Xu YC . Effects of serum containing Fructus Cnidii and Psoralea corylifolia on highly metastatic human breast cancer cell line MDA-MB-231BO and bone marrow stromal cell line ST-2[J]. J Chin Integr Med, 2010,8(9):877-882
[7] Liu S, Wu CY, Cheng XF, Yang SF, Song XY . Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer — an expatiation viewing from DPG/RANKL/RANK system[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2011,31(5):684-689
刘胜, 吴春宇, 程旭锋, 杨顺芳, 宋晓耘 . 从OPG/RANKL/RANK系统阐述补骨脂-蛇床子抑制乳腺癌骨转移的机制[J]. 中国中西医结合杂志, 2011,31(5):684-689
[8] Situ ZQ, Wu JZ. Cell culture.2th ed[M]. Xi’an: World Publishing Corporation, 2007,165
司徒镇强, 吴军正 . 细胞培养.第2版[M]. 西安: 世界图书出版公司, 2007,165
[9] Fang KT . The uniform design and its application[J]. Shu Li Tong Ji Yu Guan Li, 1994,13(1):57-66
方开泰 . 均匀设计及其应用[J]. 数理统计与管理, 1994,13(1):57-66
[10] Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method. Methods. 2001; 25(4):402-408.
doi: 10.1006/meth.2001.1262
[11] Schmierer B, Hill CS . TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility[J]. Nat Rev Mol Cell Biol, 2007,8(12):970-982
doi: 10.1038/nrm2297
[12] Lönn P, Morén A, Raja E, Dahl M, Moustakas A . Regulating the stability of TGFbeta receptors and Smads[J]. Cell Res, 2009,19(1):21-35
doi: 10.1038/cr.2008.308
[13] Park SH . Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads[J]. J Biochem Mol Biol, 2005,38(1):9-16
doi: 10.5483/BMBRep.2005.38.1.009 pmid: 15715940
[14] Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagu J . Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway[J]. Proc Natl Acad Sci U S A, 2005,102(39):13909-13914
doi: 10.1073/pnas.0506517102 pmid: 16172383
[15] Petersen M , Pardali E, van der Horst G,Cheung H, van den Hoogen C,van der Pluijm G,Ten Dijke P. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis[J]. Oncogene, 2010,29(9):1351-1361
doi: 10.1038/onc.2009.426
[16] Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S . Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells[J]. J Natl Cancer Inst, 2005,97(23):1734-1746
doi: 10.1093/jnci/dji399 pmid: 16333029
[17] Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, Falb D . The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling[J]. Cell, 1997,89(7):1165-1173
doi: 10.1016/S0092-8674(00)80303-7
[18] Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG . Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation[J]. Mol Cell Biol, 2007,27(12):4488-4499
doi: 10.1128/MCB.01636-06
[19] Sung B, Murakami A, Oyajobi BO, Aggarwal BB . Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice[J]. Cancer Res, 2009,69(4):1477-1484
doi: 10.1158/0008-5472.CAN-08-3249
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Stefania Lamponi, Anna Maria Aloisi, Claudia Bonechi, Marco Consumi, Alessandro Donati, Gemma Leone, Claudio Rossi, Gabriella Tamasi, Luana Ghiandai, Ersilia Ferrini, Paolo Fiorenzani, Ilaria Ceccarelli, Agnese Magnani. Evaluation of in vitro cell and blood compatibility and in vivo analgesic activity of plant-derived dietary supplements. Journal of Integrative Medicine, 2019, 17(3): 213-220.
[3] Supakanya Kumkarnjana, Rutt Suttisri, Ubonthip Nimmannit, Thongchai Koobkokkruad, Chutichot Pattamadilok, Nontima Vardhanabhuti . Anti-adipogenic effect of flavonoids from Chromolaena odorata leaves in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2018, 16(6): 427-434.
[4] Rohitash Jamwal. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. Journal of Integrative Medicine, 2018, 16(6): 367-374.
[5] Shohini Chakraborty, Nashra Afaq, Neelam Singh, Sukanta Majumdar. Antimicrobial activity of Cannabis sativaThuja orientalis and Psidium guajava leaf extracts against methicillin-resistant Staphylococcus aureus. Journal of Integrative Medicine, 2018, 16(5): 350-357.
[6] Bruno José Martins Da Silva, Amanda Anastácia Pinto Hage, Edilene Oliveira Silva, Ana Paula Drummond Rodrigues. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: A review. Journal of Integrative Medicine, 2018, 16(4): 211-222.
[7] Musa Toyin Yakubu, Abdulquadri Funmbi Olutoye. Aphrodisiac activity of aqueous extract of Anthonotha macrophylla P. Beauv. leaves in female Wistar rats. Journal of Integrative Medicine, 2016, 14(5): 400-408.
[8] Nisha Panth, Keshav Raj Paudel, Rajendra Karki. Phytochemical profile and biological activity of Juglans regia. Journal of Integrative Medicine, 2016, 14(5): 359-373.
[9] JiaXia, Li-qunHe, XiaoSu. Interventional mechanisms of herbs or herbal extracts on renal interstitial fibrosis. Journal of Integrative Medicine, 2016, 14(3): 165-173.
[10] Qing-qing Zang, Lu Zhang, Ning Gao, Cheng Huang. Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells. Journal of Integrative Medicine, 2016, 14(1): 51-59.
[11] Santu Kumar Saha, Sourav Roy, Anisur Rahman Khuda-Bukhsh. Ultra-highly diluted plant extracts of Hydrastis canadensis and Marsdenia condurango induce epigenetic modifications and alter gene expression profiles in HeLa cells in vitro. Journal of Integrative Medicine, 2015, 13(6): 400-411.
[12] Wei Chiang Chan Eric, Kuin Wong Siu. Phytochemistry and pharmacology of ornamental gingers, Hedychium coronarium and Alpinia purpurata: A review. Journal of Integrative Medicine, 2015, 13(6): 368-379.
[13] Rashmi Singh, Shatruhan Sharma, Veena Sharma. Comparative and quantitative analysis of antioxidant and scavenging potential of Indigofera tinctoria Linn. extracts. Journal of Integrative Medicine, 2015, 13(4): 269-278.
[14] Oluwatosin Adaramoye, Bettina Erguen, Olubukola Oyebode, Bianca Nitzsche, Michael Höpfner, Klaus Jung, Anja Rabien. Antioxidant, antiangiogenic and antiproliferative activities of root methanol extract of Calliandra portoricensis in human prostate cancer cells. Journal of Integrative Medicine, 2015, 13(3): 185-193.
[15] Swapnil P. Borse, Bhagyashree B. Kamble. Effects of Ayurvedic Rasayana botanicals on CYP3A4 isoenzyme system. Journal of Integrative Medicine, 2015, 13(3): 165-172.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239